跳至主要内容
临床试验/NCT02522741
NCT02522741撤回不适用

Safe Mothers, Safe Children Initiative

NYU Langone Health1 个研究点 分布在 1 个国家开始时间: 2010年11月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
The Clinician Administered PTSD Scale

研究概览

简要总结

The purpose of this study is to evaluate the efficacy of an evidence-based post-traumatic stress disorder (PTSD) intervention adapted to focus on parenting-related impairment for mothers receiving preventive services. The study intervention is adapted from Skills Training in Affective and Interpersonal Regulation (STAIR). The investigators expect that the adaption (Parenting STAIR) has the potential to prevent child maltreatment as well as improve maternal and child well-being by reducing the effects of maternal PTSD and depression on parenting.

The investigators plan to recruit mothers with high levels of trauma-related symptoms from preventive service agencies, and invite them to participate in the study. This study is a single group design, and data will be collected pre-treatment, post-treatment, and 12-week follow-up.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Mothers who are receiving preventive services at the time of study enrollment and have histories of trauma, have symptoms of PTSD, without a history of psychotic disorder, or current domestic violence or substance abuse
  • Have a child within the 2-9 age range, and are the child's primary caretaker
  • Can communicate in English and/or Spanish

排除标准

  • Women who have a history of psychotic disorder and/or who meet current DSM-IV criteria for abuse of drug or alcohol
  • Women who are experiencing domestic violence at the time of the assessment
  • Pregnant women are excluded from this pilot study because they are a potentially particularly vulnerable population. However, women who become pregnant while participating in the study will not be excluded
  • Women who report suicidal ideation in the past two weeks on the SCID, or have a history of a suicide attempt during the last year as reported during the SCID interview
  • Children who meet diagnostic criteria for developmental disorders (e.g., autism and mental retardation), and/or have a history of childhood psychosis

结局指标

主要结局

The Clinician Administered PTSD Scale

时间窗: Change from baseline to end of treatment (approximately 23 sessions over 23 weeks); change to post-treatment (12 weeks after completion of treatment)

Posttraumatic Stress Diagnostic Scale

时间窗: Change from baseline to end of treatment (approximately 23 sessions over 23 weeks); change to post-treatment (12 weeks after completion of treatment)

Center for Epidemiological Studies Depression Scale

时间窗: Change from baseline to end of treatment (approximately 23 sessions over 23 weeks); change to post-treatment (12 weeks after completion of treatment)

The Structured Clinical Interview for the Diagnostic & Statistical Manual of Mental Disorders (DSM)-IV Axis I Disorders

时间窗: At baseline

Woman Abuse Screening Tool

时间窗: At baseline

Strengths and Difficulties Questionnaire

时间窗: Change from baseline to end of treatment (approximately 23 sessions over 23 weeks); change to post-treatment (12 weeks after completion of treatment)

Eyberg Child Behavior Inventory

时间窗: Change from baseline to end of treatment (approximately 23 sessions over 23 weeks); change to post-treatment (12 weeks after completion of treatment)

Developmental Questionnaire

时间窗: Change from baseline to end of treatment (approximately 23 sessions over 23 weeks); change to post-treatment (12 weeks after completion of treatment)

Traumatic Events Screening Inventory - Parent Report Revised, Trauma Symptom Checklist for Young

时间窗: Change from baseline to end of treatment (approximately 23 sessions over 23 weeks); change to post-treatment (12 weeks after completion of treatment)

次要结局

  • Yale University PRIME Screening Test(At baseline for individuals not meeting criteria for PTSD)
  • Connor-Davidson Resilience Scale(Change from baseline to end of treatment (approximately 23 sessions over 23 weeks); change to post-treatment (12 weeks after completion of treatment))
  • Life Orientation Test-Revised(Change from baseline to end of treatment (approximately 23 sessions over 23 weeks); change to post-treatment (12 weeks after completion of treatment))
  • The Parenting Stress Index-Short Form(Change from baseline to end of treatment (approximately 23 sessions over 23 weeks); change to post-treatment (12 weeks after completion of treatment))
  • The Conflict Tactics Scale-Parent-Child(Change from baseline to end of treatment (approximately 23 sessions over 23 weeks); change to post-treatment (12 weeks after completion of treatment))
  • The Adult-Adolescent Parenting Inventory-2(Change from baseline to end of treatment (approximately 23 sessions over 23 weeks); change to post-treatment (12 weeks after completion of treatment))
  • CAGE Substance Abuse Screening Tool(At baseline for individuals not meeting criteria for PTSD)
  • Treatment Services Review(Change from baseline to end of treatment (approximately 23 sessions over 23 weeks); change to post-treatment (12 weeks after completion of treatme)
  • Interpersonal Support Evaluation List(Change from baseline to end of treatment (approximately 23 sessions over 23 weeks); change to post-treatment (12 weeks after completion of treatment))
  • State Trait Anger Expression Inventory-2(Change from baseline to end of treatment (approximately 23 sessions over 23 weeks); change to post-treatment (12 weeks after completion of treatment))
  • Difficulties of Emotional Regulation Scale(Change from baseline to end of treatment (approximately 23 sessions over 23 weeks); change to post-treatment (12 weeks after completion of treatment))
  • Working Alliance Inventory Short Form for Clients(Change from baseline to end of treatment (approximately 23 sessions over 23 weeks); change to post-treatment (12 weeks after completion of treatment))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Safe Mothers, Safe Children Initiative | 临床试验